Is REPH or XYLD a better dividend investment in 2026?

REPH currently yields 95.69% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: REPH offers higher current income.

What is the dividend yield difference between REPH and XYLD?

REPH has a forward dividend yield of 95.69% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 84.71 percentage points.

Home › Compare › REPH vs XYLD

REPH vs XYLD: Dividend Comparison 2026

REPH yields 95.69% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 REPH wins by $3.24M in total portfolio value

INVESTMENT

TIME HORIZON10 years

REPH

● Live price

95.69%

Share price

$2.09

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3.26M

Annual income

$1,067,397.24

Full REPH calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — REPH vs XYLD

📍 REPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	REPH	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, REPH + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

REPH pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

REPH

Annual income on $10K today (after 15% tax)

$8,133.97/yr

After 10yr DRIP, annual income (after tax)

$907,287.65/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, REPH beats the other by $904,551.49/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of REPH + XYLD for your $10,000?

REPH: 50%XYLD: 50%

100% XYLD50/50100% REPH

Portfolio after 10yr

$1.64M

Annual income

$535,308.13/yr

Blended yield

32.57%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on REPH right now

REPH

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-1.1

Piotroski

2/9

XYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

REPH buys

XYLD buys

No recent congressional trades found for REPH or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricREPHXYLD

Forward yield	95.69% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$3.26M	$25.3K ✓
Annual income after 10y	$1,067,397.24 ✓	$3,219.02
Total dividends collected	$2.90M	$19.6K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: REPH vs XYLD ($10,000, DRIP)

Year	REPH Portfolio	REPH Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$20,269	$9,569.38	$10,818	$1,098.39	+$9.5K → REPH
2	$39,816	$18,127.60	$11,738	$1,222.51	+$28.1K → REPH
3	$75,882	$33,279.13	$12,774	$1,364.64	+$63.1K → REPH
4	$140,469	$59,275.00	$13,944	$1,527.86	+$126.5K → REPH
5	$252,850	$102,548.32	$15,270	$1,715.87	+$237.6K → REPH
6	$443,065	$172,515.34	$16,775	$1,933.09	+$426.3K → REPH
7	$756,599	$282,519.41	$18,490	$2,184.87	+$738.1K → REPH
8	$1,260,443	$450,881.99	$20,450	$2,477.63	+$1.24M → REPH
9	$2,050,673	$701,999.14	$22,697	$2,819.19	+$2.03M → REPH
10	$3,261,617	$1,067,397.24	$25,280	$3,219.02	+$3.24M → REPH

REPH vs XYLD: Complete Analysis 2026

REPH — Stock

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

Full REPH Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this REPH vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

REPH vs SCHD REPH vs JEPI REPH vs O REPH vs KO REPH vs MAIN REPH vs QYLD REPH vs JEPQ REPH vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.